Article Versions Notes

Penta L, Cofini M, Lucchetti L, Zenzeri L, Leonardi A, Lanciotti L, Galeazzi D, Verrotti A, Esposito S. Growth Hormone (GH) Therapy During the Transition Period: Should We Think about Early Retesting in Patients with Idiopathic and Isolated GH Deficiency? International Journal of Environmental Research and Public Health. 2019; 16(3):307. https://doi.org/10.3390/ijerph16030307

Penta, Laura, Marta Cofini, Laura Lucchetti, Letizia Zenzeri, Alberto Leonardi, Lucia Lanciotti, Daniela Galeazzi, Alberto Verrotti, and Susanna Esposito. 2019. "Growth Hormone (GH) Therapy During the Transition Period: Should We Think about Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?" International Journal of Environmental Research and Public Health 16, no. 3: 307. https://doi.org/10.3390/ijerph16030307

Penta, L., Cofini, M., Lucchetti, L., Zenzeri, L., Leonardi, A., Lanciotti, L., Galeazzi, D., Verrotti, A., & Esposito, S. (2019). Growth Hormone (GH) Therapy During the Transition Period: Should We Think about Early Retesting in Patients with Idiopathic and Isolated GH Deficiency? International Journal of Environmental Research and Public Health, 16(3), 307. https://doi.org/10.3390/ijerph16030307